Olaf Hopfer
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 27, 2023
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial.
Journal: Nature cancer
Published: September 16, 2022
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML.
Journal: Trials
Published: April 27, 2021
Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma.
Journal: Haematologica
Published: August 11, 2019
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Journal: Annals of hematology
Published: July 10, 2017
Skewed X-inactivation patterns in ageing healthy and myelodysplastic haematopoiesis determined by a pyrosequencing based transcriptional clonality assay.
Journal: Journal of medical genetics
Published: January 23, 2013
Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
Journal: European journal of haematology
Published: October 05, 2011
DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.
Journal: Experimental hematology
Published: June 20, 2007
Showing 1-8 of 8
Last Updated: 09/26/2026